Skip to content
Search

Latest Stories

Pharmacist wins £58,000 compensation in racial harassment case against Boots

Pharmacist wins £58,000 compensation in racial harassment case against Boots

An Employment Tribunal upheld 7 claims of harassment related to race brought by the pharmacist against Boots and one of its pharmacy technicians

A tribunal has ordered Boots to pay over £58,000 in compensation and costs to a pharmacist who was racially profiled at work.

S.Famojuro, a black pharmacist of Nigerian national origin, experienced racial harassment from pharmacy team members during a shift on 18 July 2020.


The Pharmacists’ Defence Association (PDA), the independent trade union for pharmacists, represented the pharmacist throughout the internal grievance processes and at the Employment Tribunal hearing.

In a detailed written judgment, the pharmacy team members and company managers were heavily criticised by the Tribunal, after finding that a pre-registration pharmacy technician and a pharmacy advisor had undermined Famojuro in his professional role as the Responsible Pharmacist (RP) and insulted him.

The pharmacist lodged a grievance with Boots regarding his treatment, but it took the company over four months to initiate the investigation and set a meeting date, and this was only done after the PDA intervened to address the unacceptable delays.

However, the Judge described the grievance investigation conducted by an experienced store manager as “simply not fit for purpose” and lacking a “basic level of competence.”

The grievance manager was found to be inadequately trained for conducting grievances into serious allegations of discrimination, and there were unacceptable delays in dealing with the complaints.

The Tribunal concluded that Boots' actions had seriously damaged the relationship of mutual trust and confidence, leading to Famojuro's resignation, which was determined to be a case of constructive unfair dismissal.

The grievance outcome was issued on 15 January 2021, with all of the pharmacist's complaints being dismissed, except for one regarding delays in the investigation.

Unsatisfied, the pharmacist appealed against the outcome, leading to the appointment of an area manager to hear the appeal.

However, the appeal manager did nothing to probe further the conduct of the pharmacy technician and pharmacy advisor, with the Tribunal noting that his inquiry was "superficial and lacked insight."

After receiving the appeal outcome, the pharmacist resigned with a notice on 3 April 2021. The apology arrived on 12 May 2021, almost 6 weeks after his resignation.

The Tribunal described this as “the classic formulation of a non-apology” noting that it “must have rubbed salt in the Claimant’s wounds”.

Following a 5-day hearing earlier this year, the Tribunal upheld 7 claims of harassment related to race brought by the pharmacist against Boots and the pharmacy technician, as well as his claim of constructive unfair dismissal.

In a remedy hearing, the Tribunal awarded Famojuro £45,263.11 for loss of earnings, injury to feelings, aggravated damages, an uplift for failure to follow the ACAS Code, and interest. Additionally, costs of £13,357.25 were awarded to the PDA, bringing the total compensation and costs to £58,620.36.

Mark Pitt, General Secretary of the PDA Union said: “Rather than properly investigate Mr Famojuro’s complaints and condemn the racist behaviour of their employees at the time of the incident, the company supported them throughout, denying any racism had occurred.

“Consequently, Mr Famojuro was put through 4 years of stress and court proceedings to secure justice for his discriminatory treatment.

“The PDA legal team have been behind him all the way and the high award and aggravated damages reflect the extreme displeasure of the employment tribunal panel at the conduct of company and its witnesses, some of whom were found to have lied and fabricated evidence. “

Wai Chan, Vice President of the PDA BAME Pharmacists Network which leads anti-racist activity for the PDA, stated that they will review this case to inform their future activity.”

The PDA emphasised that unlawful discrimination related to race is unacceptable, and urges members who encounter discrimination at work to seek advice from the PDA Member Support Centre.

More For You

Youth vaping : project to examine health impacts on children

Youth vaping : project to examine health impacts on children

Youth vaping: £62M research project to examine health impacts on children

The UK government has announced a £62 million research project to investigate the long-term health effects of vaping on young people, alongside wider influences on adolescent health and wellbeing.

While vaping is considered less harmful than smoking and can aid adult smokers in quitting, youth vaping has skyrocketed in recent years, with a quarter of 11 to 15-year-olds having tried it, the Department of Health and Social Care (DHSC) noted in a release.

Keep ReadingShow less
David Thomas Steps In as NPA’s New Wales Representative
Five NPA members are contesting for the remaining position in England (gettyimages)

NPA board update: David Thomas succeeds Raj Aggarwal OBE

Five NPA members are contesting for the remaining position in England

David Thomas, owner of LT Chemists in Newport, will replace Raj Aggarwal OBE as the next National Pharmacy Association (NPA) board member for Wales, following an uncontested election this month.

Following the conclusion of a nomination process last week, Baldev Bange, Aisling O’Brien, Sehar Shahid, and Sanjay Ganvir have been re-elected to the Board, representing areas of England and Scotland, according to a statement from NPA.

Keep ReadingShow less
Public Policy Projects calls for better use of community pharmacy skill mix to improve medicines adherence
Non-adherence to medicines remains a critical issue, with an estimated 30 to 50 per cent of medicines for long-term conditions not taken as prescribed. (gettyimages)

Leverage pharmacy skill mix to improve medicines adherence - report suggests

The report also suggested expanding the community pharmacy contractual framework to enable community pharmacy to deliver medicines reviews

Pharmacy technicians and assistants should be enabled to talk to patients about their medications to improve medicines adherence, a new report has recommended.

The report, How medicines optimisation contributes to population health, published recently by policy institute Public Policy Projects, highlighted that non-adherence to medicines remains a critical issue, with an estimated 30 to 50 per cent of medicines for long-term conditions not taken as prescribed.

Keep ReadingShow less
GHP calls for 10% mandated protected learning time for NHS pharmacists in new campaign
Many pharmacists end up doing ‘unpaid work’ to catch up with the required training (gettyimages)

Increase protected learning time for NHS pharmacists – GHP launches national campaign

Many pharmacists end up doing ‘unpaid work’ to catch up with the required training or completing self-learning in their own time.

The Guild of Healthcare Pharmacists (GHP) has launched a national campaign advocating for pharmacists working in the NHS to have a minimum of 10% of their contracted hours protected for supporting professional activities (SPA).

In a statement published on 7 February 2025, the GHP emphasised that this protected time “should be recognized by employers and embedded in job plans.”

Keep ReadingShow less
Pharmacy contract consultation to review medicine margin and reimbursement, says Kinnock

Pharmacy contract consultation to review medicine margin and reimbursement, says Kinnock

Kinnock confirms that an announcement on the 2025/26 GP contract would be made before April 2025

The 2025/26 pharmacy contract consultation will include a review of the medicine margin and reimbursement arrangements, health and care minister Stephen Kinnock has confirmed.

Kinnock made this statement in response to a written question from Nick Timothy, Conservative MP for West Suffolk, who asked the secretary of state for health and social care, if he will review the reimbursement system for pharmacies and GP practices dispensing medicines.

Keep ReadingShow less